Our legal basis

The establishment of the World Diabetes Foundation (WDF)was announced by its founding father Novo Nordisk A/S on World Diabetes Day 2002. A donation programme by the founding company of a maximum of DKK 650 million over a period of ten years was approved by its General Assembly and shareholders in March 2002. In March 2008, the shareholders of Novo Nordisk A/S approved of an additional endowment of a maximum of DKK 575 million over another ten year-period, bringing the two endowments from Novo Nordisk A/S up to a total maximum of DKK 1.225 billion in the period 2001 - 2017, i.e. equivalent to USD 255 million (exch. rate 4.8). The Foundation is a independent and non-profit foundation governed by the Danish Act on Foundations. The Foundation is supervised by the Civil Affairs Agency, Danish authority for non-commercial foundations. The World Diabetes Foundation is entitled by the Danish taxation authorities to receive donations from individuals and legal entities. The Foundation is governed by a six-member board of directors under the chairmanship of Prof. Pierre Lèfebvre. Day-to-day operations are vested in the WDF Secretariat under the management of Dr. Anil Kapur, Managing Director. Click here for Articles of Association  Click here for Rules of Procedure Click here for Code of Conduct

With effect from the 2002 financial year PriceWaterhouseCoopers is appointed auditors of the World Diabetes Foundation. Click here for our fully updated           Annual Audited Accounts for 2007